FI971193A - Hoidossa käyttökelpoisia kinoksaliinijohdannaisia - Google Patents
Hoidossa käyttökelpoisia kinoksaliinijohdannaisia Download PDFInfo
- Publication number
- FI971193A FI971193A FI971193A FI971193A FI971193A FI 971193 A FI971193 A FI 971193A FI 971193 A FI971193 A FI 971193A FI 971193 A FI971193 A FI 971193A FI 971193 A FI971193 A FI 971193A
- Authority
- FI
- Finland
- Prior art keywords
- pct
- alkyl
- therapeutically useful
- quinoxaline derivatives
- date mar
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Luminescent Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9419318A GB9419318D0 (en) | 1994-09-24 | 1994-09-24 | Therapeutic agents |
| PCT/EP1995/003559 WO1996009295A1 (en) | 1994-09-24 | 1995-09-08 | Quinoxaline derivatives useful in therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI971193A0 FI971193A0 (fi) | 1997-03-21 |
| FI971193A true FI971193A (fi) | 1997-05-21 |
Family
ID=10761869
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI971193A FI971193A (fi) | 1994-09-24 | 1997-03-21 | Hoidossa käyttökelpoisia kinoksaliinijohdannaisia |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US5852016A (fi) |
| EP (1) | EP0783495B1 (fi) |
| JP (1) | JP2986920B2 (fi) |
| KR (1) | KR970706261A (fi) |
| CN (1) | CN1158610A (fi) |
| AT (1) | ATE213731T1 (fi) |
| AU (1) | AU688591B2 (fi) |
| BR (1) | BR9504132A (fi) |
| CA (1) | CA2200742C (fi) |
| CO (1) | CO4410336A1 (fi) |
| CZ (1) | CZ85797A3 (fi) |
| DE (1) | DE69525633T2 (fi) |
| DK (1) | DK0783495T3 (fi) |
| ES (1) | ES2171553T3 (fi) |
| FI (1) | FI971193A (fi) |
| GB (1) | GB9419318D0 (fi) |
| HU (1) | HUT77734A (fi) |
| IL (2) | IL115334A0 (fi) |
| MX (1) | MX9702259A (fi) |
| NO (1) | NO971261L (fi) |
| NZ (1) | NZ292922A (fi) |
| PE (1) | PE47596A1 (fi) |
| PL (1) | PL319405A1 (fi) |
| PT (1) | PT783495E (fi) |
| RU (1) | RU2135484C1 (fi) |
| TR (1) | TR199501158A2 (fi) |
| WO (1) | WO1996009295A1 (fi) |
| ZA (1) | ZA958023B (fi) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY132385A (en) * | 1995-08-31 | 2007-10-31 | Novartis Ag | 2,3-dioxo-1,2,3,4-tetrahydro-quinoxalinyl derivatives |
| ATE212842T1 (de) * | 1995-10-10 | 2002-02-15 | Pfizer | Quinoxalin-derivate zur behandlung von tinnitus |
| GB9604400D0 (en) | 1996-03-01 | 1996-05-01 | Pfizer Ltd | Compounds useful in therapy |
| WO1997046539A1 (en) * | 1996-06-05 | 1997-12-11 | Warner-Lambert Company | Amide derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists |
| US5721256A (en) * | 1997-02-12 | 1998-02-24 | Gpi Nil Holdings, Inc. | Method of using neurotrophic sulfonamide compounds |
| HUP0001311A3 (en) * | 1997-02-18 | 2001-07-30 | American Home Products Corp Ma | 5-aminoalkoxy-1,4-dihydroquinoxaline-2,3-diones being dopamine agonists and pharmaceutical compositions containing them |
| US5922715A (en) * | 1997-02-18 | 1999-07-13 | American Home Products Corporation | 5-aminoalkoxy-1, 4-dihydroquinoxaline-2, 3-diones |
| TW403740B (en) | 1997-06-10 | 2000-09-01 | Novartis Ag | Novel crystal modifications of the compound 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide |
| GB0310881D0 (en) * | 2003-05-12 | 2003-06-18 | Merck Sharp & Dohme | Pharmaceutical formulation |
| US10208000B2 (en) | 2015-12-16 | 2019-02-19 | University Of Kentucky Research Foundation | Eis inhibitors |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE572852C (de) * | 1931-03-08 | 1933-03-24 | Willy Messerschmitt Dipl Ing | Verfahren zur Herstellung von Flugzeugtragfluegeln mit trapezfoermigem Grundriss |
| DK146787A (da) * | 1987-03-23 | 1988-09-24 | Ferrosan | Heterocykliske forbindelser, deres fremstilling og anvendelse |
| DK715888D0 (da) * | 1988-12-22 | 1988-12-22 | Ferrosan As | Quinoxalinforbindelser, deres fremstilling og anvendelse |
| DK0556393T3 (da) * | 1990-11-06 | 2000-10-16 | Yamanouchi Pharma Co Ltd | Tilkondenseret pyrazinderivat |
| DE4123106A1 (de) * | 1991-07-09 | 1993-01-14 | Schering Ag | Arzneimittel zur behandlung von entzugssymptomen |
| PT101004B (pt) * | 1991-10-26 | 1999-10-29 | Schering Ag | Derivados da quinoxalina, processo para a sua preparacao e composicoes farmaceuticas que os contem |
| DE4217952A1 (de) * | 1992-05-30 | 1993-12-02 | Basf Ag | Chinoxalin-2,3(1H,4H)-dione |
| EP0647137B1 (en) * | 1992-06-22 | 2008-08-13 | The Regents Of The University Of California | Glycine receptor antagonists and the use thereof |
| IL109397A0 (en) * | 1993-04-28 | 1994-07-31 | Schering Ag | Quinoxalinedione derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same |
| DE4439493A1 (de) * | 1994-10-25 | 1996-05-02 | Schering Ag | Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln |
| DE4439492A1 (de) * | 1994-10-25 | 1996-05-02 | Schering Ag | Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln |
| US5614508A (en) * | 1995-06-07 | 1997-03-25 | Warner-Lambert Company | Amino acid derivatives of substituted quinoxaline 2,3-dione derivatives as glutamate receptor antagonists |
-
1994
- 1994-09-24 GB GB9419318A patent/GB9419318D0/en active Pending
-
1995
- 1995-09-08 US US08/809,337 patent/US5852016A/en not_active Expired - Fee Related
- 1995-09-08 HU HU9800754A patent/HUT77734A/hu unknown
- 1995-09-08 PT PT95932021T patent/PT783495E/pt unknown
- 1995-09-08 ES ES95932021T patent/ES2171553T3/es not_active Expired - Lifetime
- 1995-09-08 DE DE69525633T patent/DE69525633T2/de not_active Expired - Fee Related
- 1995-09-08 CZ CZ97857A patent/CZ85797A3/cs unknown
- 1995-09-08 KR KR1019970701887A patent/KR970706261A/ko active IP Right Grant
- 1995-09-08 EP EP95932021A patent/EP0783495B1/en not_active Expired - Lifetime
- 1995-09-08 CN CN95195253A patent/CN1158610A/zh active Pending
- 1995-09-08 PL PL95319405A patent/PL319405A1/xx unknown
- 1995-09-08 DK DK95932021T patent/DK0783495T3/da active
- 1995-09-08 NZ NZ292922A patent/NZ292922A/en unknown
- 1995-09-08 CA CA002200742A patent/CA2200742C/en not_active Expired - Fee Related
- 1995-09-08 AU AU35232/95A patent/AU688591B2/en not_active Ceased
- 1995-09-08 AT AT95932021T patent/ATE213731T1/de not_active IP Right Cessation
- 1995-09-08 MX MX9702259A patent/MX9702259A/es not_active IP Right Cessation
- 1995-09-08 WO PCT/EP1995/003559 patent/WO1996009295A1/en active IP Right Grant
- 1995-09-08 RU RU97107018A patent/RU2135484C1/ru active
- 1995-09-08 JP JP8510561A patent/JP2986920B2/ja not_active Expired - Fee Related
- 1995-09-18 IL IL11533495A patent/IL115334A0/xx unknown
- 1995-09-20 PE PE1995279512A patent/PE47596A1/es not_active Application Discontinuation
- 1995-09-22 BR BR9504132A patent/BR9504132A/pt not_active IP Right Cessation
- 1995-09-22 ZA ZA958023A patent/ZA958023B/xx unknown
- 1995-09-22 CO CO95043930A patent/CO4410336A1/es unknown
- 1995-09-22 TR TR95/01158A patent/TR199501158A2/xx unknown
-
1997
- 1997-03-19 NO NO971261A patent/NO971261L/no unknown
- 1997-03-21 FI FI971193A patent/FI971193A/fi unknown
-
1998
- 1998-09-07 IL IL12610498A patent/IL126104A0/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TR199501158A2 (tr) | 1997-02-21 |
| WO1996009295A1 (en) | 1996-03-28 |
| PT783495E (pt) | 2002-07-31 |
| AU688591B2 (en) | 1998-03-12 |
| FI971193A0 (fi) | 1997-03-21 |
| KR970706261A (ko) | 1997-11-03 |
| NO971261D0 (no) | 1997-03-19 |
| DK0783495T3 (da) | 2002-04-22 |
| PE47596A1 (es) | 1996-11-12 |
| NO971261L (no) | 1997-05-05 |
| CZ85797A3 (cs) | 1998-09-16 |
| NZ292922A (en) | 1998-07-28 |
| RU2135484C1 (ru) | 1999-08-27 |
| ATE213731T1 (de) | 2002-03-15 |
| EP0783495B1 (en) | 2002-02-27 |
| CA2200742C (en) | 2001-09-11 |
| JP2986920B2 (ja) | 1999-12-06 |
| CO4410336A1 (es) | 1997-01-09 |
| DE69525633T2 (de) | 2002-08-08 |
| JPH09511526A (ja) | 1997-11-18 |
| HUT77734A (hu) | 1998-07-28 |
| PL319405A1 (en) | 1997-08-04 |
| MX9702259A (es) | 1997-06-28 |
| EP0783495A1 (en) | 1997-07-16 |
| IL126104A0 (en) | 1999-05-09 |
| ES2171553T3 (es) | 2002-09-16 |
| CN1158610A (zh) | 1997-09-03 |
| GB9419318D0 (en) | 1994-11-09 |
| BR9504132A (pt) | 1996-08-06 |
| CA2200742A1 (en) | 1996-03-28 |
| IL115334A0 (en) | 1995-12-31 |
| US5852016A (en) | 1998-12-22 |
| AU3523295A (en) | 1996-04-09 |
| ZA958023B (en) | 1997-03-24 |
| DE69525633D1 (de) | 2002-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69429078D1 (de) | Pharmacologisch wirksame pyridinderivate und verfahren zu deren herstellung | |
| DK0574313T3 (da) | 1,4-disubstituerede piperaziner til behandling af sygdomme i centralnervesystemet og neuroendocrine sygdomme | |
| DK0775129T3 (da) | 3-Benzoylbenzofuranderivater som thyroidhormonantagonister | |
| ES2181853T3 (es) | Tratamiento del tinnitus empleando agentes neuroprotectores. | |
| DK0641325T3 (da) | Inhibitorer af retroviral protease | |
| TR199802060T2 (xx) | Aminoisokinolinler ve aminopiridin t�revlerinin iltihap �nleyiciler olarak kullan�m�. | |
| SE9703414D0 (sv) | New compounds | |
| FI971193A (fi) | Hoidossa käyttökelpoisia kinoksaliinijohdannaisia | |
| ATE187461T1 (de) | Cyklopeptolide | |
| ATE250027T1 (de) | Azetidincarboxamidderivate zur behandlung von zns-erkrankungen | |
| DK0784973T3 (da) | Quinoxalinderivater til behandling af tinnitus | |
| ECSP951538A (es) | Derivados de quinoxalina utiles en terapia |